The role of pleurodesis in respiratory diseases

References

• Rodriguez-Panadero F, Montes-Worboys A. Mechanisms of pleurodesis. Respiration. 2012;83(2):91–98.
   PubMed Web of Science ®Google Scholar
• Roberts ME, Neville E, Berrisford RG, et al. Management of a malignant pleural effusion: British Thoracic Society Pleural Disease Guideline 2010. Thorax. 2010;65(Suppl 2):ii32–40.
   PubMed Web of Science ®Google Scholar
• Sharkey AJ, Rao JN. The successful use of octreotide in the treatment of traumatic chylothorax. Tex Heart Inst J. 2012;39(3):428–430.
   PubMed Web of Science ®Google Scholar
• MacDuff A, Arnold A, Harvey J. Management of spontaneous pneumothorax: British Thoracic Society Pleural Disease Guideline 2010. Thorax. 2010;65(Suppl 2):ii18–31.
   PubMed Web of Science ®Google Scholar
• Curtis HJ, Bourke SJ, Dark JH, et al. Lung transplantation outcome in cystic fibrosis patients with previous pneumothorax. J Heart Lung Transplant. 2005;24(7):865–869.
   PubMed Web of Science ®Google Scholar
• Dusmet M, Winton TL, Kesten S, et al. Previous intrapleural procedures do not adversely affect lung transplantation. J Heart Lung Transplant. 1996;15(3):249–254.
   PubMed Web of Science ®Google Scholar
• Rolla M, Anile M, Venuta F, et al. Lung transplantation for cystic fibrosis after thoracic surgical procedures. Transplant Proc. 2011;43(4):1162–1163.
   PubMed Web of Science ®Google Scholar
• Maskell NA, Lee YC, Gleeson FV, et al. Randomized trials describing lung inflammation after pleurodesis with talc of varying particle size. Am J Respir Crit Care Med. 2004;170(4):377–382.
   PubMed Web of Science ®Google Scholar
• Dresler CM, Olak J, Herndon JE, et al. Phase III intergroup study of talc poudrage vs talc slurry sclerosis for malignant pleural effusion. Chest. 2005;127(3):909–915.
   PubMed Web of Science ®Google Scholar
• Davies HE, Mishra EK, Kahan BC, et al. Effect of an indwelling pleural catheter vs chest tube and talc pleurodesis for relieving dyspnea in patients with malignant pleural effusion: the TIME2 randomized controlled trial. JAMA. 2012;307(22):2383–2389.
   PubMed Web of Science ®Google Scholar
• Bhatnagar R, Kahan BC, Morley AJ, et al. The efficacy of indwelling pleural catheter placement versus placement plus talc sclerosant in patients with malignant pleural effusions managed exclusively as outpatients (IPC-PLUS): study protocol for a randomised controlled trial. Trials. 2015;16:48.
   PubMed Web of Science ®Google Scholar
• Sonoda A, Jeudy J, White CS, et al. Pleurodesis: indications and radiologic appearance. Jpn J Radiol. 2015;33(5):241–245.
   PubMed Web of Science ®Google Scholar
• Murray JF, Mason R, editor. Murray and Nadel’s textbook of respiratory medicine. Philadelphia (PA): Saunders/Elsevier; 2010.
   Google Scholar
• Ibrahim IM, Dokhan AL, El-Sessy AA, et al. Povidone-iodine pleurodesis versus talc pleurodesis in preventing recurrence of malignant pleural effusion. J Cardiothorac Surg. 2015;10:64.
   PubMed Web of Science ®Google Scholar
• Ahmed L, Ip H, Rao D, et al. Talc pleurodesis through indwelling pleural catheters for malignant pleural effusions: retrospective case series of a novel clinical pathway. Chest. 2014;146(6):e190–e194.
   PubMed Web of Science ®Google Scholar
• Leo F, Dellamonica J, Venissac N, et al. Can chest ultrasonography assess pleurodesis after VATS for spontaneous pneumothorax? Eur J Cardio Thoracic Surg. 2005;28(1):47–49.
   PubMed Web of Science ®Google Scholar
• Paschoalini Mda S, Vargas FS, Marchi E, et al. Prospective randomized trial of silver nitrate vs talc slurry in pleurodesis for symptomatic malignant pleural effusions. Chest. 2005;128(2):684–689.
   PubMed Web of Science ®Google Scholar
• Janssen JP, Collier G, Astoul P, et al. Safety of pleurodesis with talc poudrage in malignant pleural effusion: a prospective cohort study. Lancet (London, England). 2007;369(9572):1535–1539.
   PubMed Web of Science ®Google Scholar
• Chen JS, Chan WK, Tsai KT, et al. Simple aspiration and drainage and intrapleural minocycline pleurodesis versus simple aspiration and drainage for the initial treatment of primary spontaneous pneumothorax: an open-label, parallel-group, prospective, randomised, controlled trial. Lancet (London, England). 2013;381(9874):1277–1282.
   PubMed Web of Science ®Google Scholar
• Yilmaz N, Zeybek A, Tharian B, et al. Efficacy of nonsurgical tigecycline pleurodesis for the management of hepatic hydrothorax in patients with liver cirrhosis. Surg Case Rep. 2015;1(1):62.
   PubMedGoogle Scholar
• Barbetakis N, Vassiliadis M, Kaplanis K, et al. Mitoxantrone pleurodesis to palliate malignant pleural effusion secondary to ovarian cancer. BMC Palliative Care. 2004;3(1):4.
   PubMedGoogle Scholar
• Sasaki T, Yasuda H, Nakayama K, et al. Pleurodesis with carboplatin in elderly patients with malignant pleural effusion and lung adenocarcinoma. J Am Geriatr Soc. 2006;54(4):722–723.
   PubMed Web of Science ®Google Scholar
• Bilaceroglu S, Cagirici U, Perim K, et al. Corynebacterium parvum pleurodesis and survival is not significantly influenced by pleural pH and glucose level. Monaldi Arch Chest Dis = Archivio Monaldi per le malattie del torace. 1998;53(1):14–22.
   PubMedGoogle Scholar
• Stumpf C, Bussing A. Stimulation of antitumour immunity by intrapleural instillation of a Viscum album L. extract. Anti-Cancer Drugs. 1997;8(Suppl 1):S23–S26.
   PubMedGoogle Scholar
• Rauthe G, Sistermanns J. Pleurodesis with recombinant tumour necrosis factor in gynaecological neoplasms. Eur J Gynaecol Oncol. 1998;19(2):108–112.
   PubMed Web of Science ®Google Scholar
• Alamdari DH, Asadi M, Rahim AN, et al. Efficacy and safety of pleurodesis using platelet-rich plasma and fibrin glue in management of postoperative chylothorax after esophagectomy. World J Surg. 2017.
   PubMedGoogle Scholar
• Torre M, Grassi M, Nerli FP, et al. Nd-YAG laser pleurodesis via thoracoscopy. Endoscopic therapy in spontaneous pneumothorax Nd-YAG laser pleurodesis. Chest. 1994;106(2):338–341.
   PubMed Web of Science ®Google Scholar
• Lee YC, Baumann MH, Maskell NA, et al. Pleurodesis practice for malignant pleural effusions in five English-speaking countries: survey of pulmonologists. Chest. 2003;124(6):2229–2238.
   PubMed Web of Science ®Google Scholar
• Haddad FJ, Younes RN, Gross JL, et al. Pleurodesis in patients with malignant pleural effusions: talc slurry or bleomycin? Results of a prospective randomized trial. World J Surg. 2004;28(8):749–53; discussion 53–4.
   PubMed Web of Science ®Google Scholar
• Vargas FS, Carmo AO, Teixeira LR. A new look at old agents for pleurodesis: nitrogen mustard, sodium hydroxide, and silver nitrate. Curr Opin Pulm Med. 2000;6(4):281–286.
   PubMedGoogle Scholar
• Ukale V, Agrenius V, Hillerdal G, et al. Pleurodesis in recurrent pleural effusions: a randomized comparison of a classical and a currently popular drug. Lung Cancer. 2004;43(3):323–328.
   PubMed Web of Science ®Google Scholar
• Hallifax RJ, Yousuf A, Jones HE, et al. Effectiveness of chemical pleurodesis in spontaneous pneumothorax recurrence prevention: a systematic review. Thorax. 2017;72(12):1121–1131.
   PubMed Web of Science ®Google Scholar
• Bernard A, de Dompsure RB, Hagry O, et al. Early and late mortality after pleurodesis for malignant pleural effusion. Ann Thorac Surg. 2002;74(1):213–217.
   PubMed Web of Science ®Google Scholar
• Shaw P, Agarwal R. Pleurodesis for malignant pleural effusions. Cochrane Database Syst Rev. 2004;Cd002916.
   PubMedGoogle Scholar
• Diacon AH, Wyser C, Bolliger CT, et al. Prospective randomized comparison of thoracoscopic talc poudrage under local anesthesia versus bleomycin instillation for pleurodesis in malignant pleural effusions. Am J Respir Crit Care Med. 2000;162(4 Pt 1):1445–1449.
   PubMed Web of Science ®Google Scholar
• Tabatabaei SA, Hashemi SM, Kamali A. Silver nitrate versus tetracycline in pleurodesis for malignant pleural effusions; a prospective randomized trial. Adv Biomed Res. 2015;4:178.
   PubMedGoogle Scholar
• Huggins JT, Doelken P, Sahn SA. Intrapleural therapy. Respirology (Carlton, Vic). 2011;16(6):891–899.
   PubMed Web of Science ®Google Scholar
• Rahman NM, Pepperell J, Rehal S, et al. Effect of opioids vs NSAIDs and larger vs smaller chest tube size on pain control and pleurodesis efficacy among patients with malignant pleural effusion: the TIME1 randomized clinical trial. JAMA. 2015;314(24):2641–2653.
   PubMed Web of Science ®Google Scholar
• Froudarakis ME, Pataka A, Makris D, et al. Respiratory muscle strength and lung function in patients undergoing medical thoracoscopy. Respiration. 2010;80(3):220–227.
   PubMed Web of Science ®Google Scholar
• Ukale V, Bone D, Hillerdal G, et al. The impact of pleurodesis in malignant effusion on respiratory function. Respir Med. 1999;93(12):898–902.
   PubMed Web of Science ®Google Scholar
• Gingell JC. Treatment of chylothorax by producing pleurodesis using iodized talc. Thorax. 1965;20:261–269.
   PubMed Web of Science ®Google Scholar
• Ukale V, Agrenius V, Widstrom O, et al. Inflammatory parameters after pleurodesis in recurrent malignant pleural effusions and their predictive value. Respir Med. 2004;98(12):1166–1172.
   PubMed Web of Science ®Google Scholar
• Gonzalez AV, Bezwada V, Beamis JF, et al. Lung injury following thoracoscopic talc insufflation: experience of a single North American center. Chest. 2010;137(6):1375–1381.
   PubMed Web of Science ®Google Scholar
• Bhatnagar R, Laskawiec-Szkonter M, Piotrowska HE, et al. Evaluating the efficacy of thoracoscopy and talc poudrage versus pleurodesis using talc slurry (TAPPS trial): protocol of an open-label randomised controlled trial. BMJ Open. 2014;4(11):e007045.
   PubMed Web of Science ®Google Scholar
• Hatata EA, Daabis RG, El Sabaa BM, et al. Doxycycline poudrage: an old agent for a new technique. Egypt J Chest Dis Tuberc. 2017;66:331–338.
   Web of Science ®Google Scholar
• Pulsiripunya C, Youngchaiyud P, Pushpakom R, et al. The efficacy of doxycycline as a pleural sclerosing agent in malignant pleural effusion: a prospective study. Respirology (Carlton, Vic). 1996;1(1):69–72.
   PubMedGoogle Scholar
• Agarwal R, Aggarwal AN, Gupta D, et al. Efficacy and safety of iodopovidone in chemical pleurodesis: a meta-analysis of observational studies. Respir Med. 2006;100(11):2043–2047.
   PubMed Web of Science ®Google Scholar
• Mohsen TA, Zeid AA, Meshref M, et al. Local iodine pleurodesis versus thoracoscopic talc insufflation in recurrent malignant pleural effusion: a prospective randomized control trial. Eur J Cardio Thoracic Surg. 2011;40(2):282–286.
   PubMed Web of Science ®Google Scholar
• Tremblay A, Dumitriu S, Stather DR, et al. Use of a drug eluting pleural catheter for pleurodesis. Exp Lung Res. 2012;38(9–10):475–482.
   PubMed Web of Science ®Google Scholar
• Bhatnagar R, Zahan-Evans N, Kearney C, et al. A novel drug-eluting indwelling pleural catheter for the management of malignant effusions. Am J Respir Crit Care Med. 2018;197(1):136–138.
   PubMed Web of Science ®Google Scholar
• Fysh ET, Tremblay A, Feller-Kopman D, et al. Clinical outcomes of indwelling pleural catheter-related pleural infections: an international multicenter study. Chest. 2013;144(5):1597–1602.
   PubMed Web of Science ®Google Scholar
• Ren S, Terman DS, Bohach G, et al. Intrapleural staphylococcal superantigen induces resolution of malignant pleural effusions and a survival benefit in non-small cell lung cancer. Chest. 2004;126(5):1529–1539.
   PubMed Web of Science ®Google Scholar
• Luh KT, Yang PC, Kuo SH, et al. Comparison of OK-432 and mitomycin C pleurodesis for malignant pleural effusion caused by lung cancer. A randomized trial. Cancer. 1992;69(3):674–679.
   PubMed Web of Science ®Google Scholar
• Rahman NM, Davies HE, Salzberg M, et al. Use of lipoteichoic acid-T for pleurodesis in malignant pleural effusion: a phase I toxicity and dose-escalation study. Lancet Oncol. 2008;9(10):946–952.
   PubMed Web of Science ®Google Scholar
• Dikensoy O, Zhu Z, Donnelly E, et al. Combination therapy with intrapleural doxycycline and talc in reduced doses is effective in producing pleurodesis in rabbits. Chest. 2005;128(5):3735–3742.
   PubMed Web of Science ®Google Scholar
• Reddy C, Ernst A, Lamb C, et al. Rapid pleurodesis for malignant pleural effusions: a pilot study. Chest. 2011;139(6):1419–1423.
   PubMed Web of Science ®Google Scholar
• Clive AO, Jones HE, Bhatnagar R, et al. Interventions for the management of malignant pleural effusions: a network meta-analysis. Cochrane Database Syst Rev. 2016;5:Cd010529.
   Google Scholar
• Xia H, Wang XJ, Zhou Q, et al. Efficacy and safety of talc pleurodesis for malignant pleural effusion: a meta-analysis. PloS One. 2014;9(1):e87060.
   PubMed Web of Science ®Google Scholar
• Chen J, Li Z, Xu N, et al. Efficacy of medical thoracoscopic talc pleurodesis in malignant pleural effusion caused by different types of tumors and different pathological classifications of lung cancer. Int J Clin Exp Med. 2015;8(10):18945–18953.
   PubMed Web of Science ®Google Scholar
• Fysh ET, Tan SK, Read CA, et al. Pleurodesis outcome in malignant pleural mesothelioma. Thorax. 2013;68(6):594–596.
   PubMed Web of Science ®Google Scholar
• Korsic M, Badovinac S, Cucevic B, et al. Talc pleurodesis improves survival of patients with malignant pleural effusions: case-control study. Wien Klin Wochenschr. 2015;127(23–24):963–969.
   PubMed Web of Science ®Google Scholar
• Barbetakis N, Asteriou C, Papadopoulou F, et al. Early and late morbidity and mortality and life expectancy following thoracoscopic talc insufflation for control of malignant pleural effusions: a review of 400 cases. J Cardiothorac Surg. 2010;5:27.
   PubMed Web of Science ®Google Scholar
• Cardillo G, Facciolo F, Carbone L, et al. Long-term follow-up of video-assisted talc pleurodesis in malignant recurrent pleural effusions. Eur J Cardio Thoracic Surg. 2002;21(2):302–305; discussion 5–6.
   PubMed Web of Science ®Google Scholar
• Vlahu T, Vigneswaran WT. Pleurectomy and decortication. Ann Transl Med. 2017;5(11):246.
   PubMed Web of Science ®Google Scholar
• Rintoul RC, Ritchie AJ, Edwards JG, et al. Efficacy and cost of video-assisted thoracoscopic partial pleurectomy versus talc pleurodesis in patients with malignant pleural mesothelioma (MesoVATS): an open-label, randomised, controlled trial. Lancet (London, England). 2014;384(9948):1118–1127.
   PubMed Web of Science ®Google Scholar
• Putnam JB Jr, Light RW, Rodriguez RM, et al. A randomized comparison of indwelling pleural catheter and doxycycline pleurodesis in the management of malignant pleural effusions. Cancer. 1999;86(10):1992–1999.
   PubMed Web of Science ®Google Scholar
• Wahidi MM, Reddy C, Yarmus L, et al. Randomized trial of pleural fluid drainage frequency in patients with malignant pleural effusions. The ASAP trial. Am J Respir Crit Care Med. 2017;195(8):1050–1057.
   PubMed Web of Science ®Google Scholar
• Corcoran JP, Wrightson JM, Belcher E, et al. Pleural infection: past, present, and future directions. Lancet Respir Med. 2015;3(7):563–577.
   PubMed Web of Science ®Google Scholar
• Bibby AC, Clive AO, Slade GC, et al. Survival in patients with malignant pleural effusions who developed pleural infection: a retrospective case review from six UK centers. Chest. 2015;148(1):235–241.
   PubMed Web of Science ®Google Scholar
• Ahmed L, Ip H, Rao D, et al. Talc pleurodesis through indwelling pleural catheters for malignant pleural effusions. Chest. 2014;146(6):e190–e194
   PubMed Web of Science ®Google Scholar
• Cagirici U, Sahin B, Cakan A, et al. Autologous blood patch pleurodesis in spontaneous pneumothorax with persistent air leak. Scand Cardiovasc J. 1998;32(2):75–78.
   PubMed Web of Science ®Google Scholar
• Evman S, Alpay L, Metin S, et al. The efficacy and economical benefits of blood patch pleurodesis in secondary spontaneous pneumothorax patients. Kardiochirurgia i torakochirurgia polska = Pol J Cardio Thoracic Surg. 2016;13(1):21–25.
   PubMed Web of Science ®Google Scholar
• Athanassiadi K, Bagaev E, Haverich A. Autologous blood pleurodesis for persistent air leak. Thorac Cardiovasc Surg. 2009;57(8):476–479.
   PubMed Web of Science ®Google Scholar
• Ozpolat B. Autologous blood patch pleurodesis in the management of prolonged air leak. Thorac Cardiovasc Surg. 2010;58(1):52–54.
   PubMed Web of Science ®Google Scholar
• Rinaldi S, Felton T, Bentley A. Blood pleurodesis for the medical management of pneumothorax. Thorax. 2009;64(3):258.
   PubMed Web of Science ®Google Scholar
• Sudduth CL, Shinnick JK, Geng Z, et al. Optimal surgical technique in spontaneous pneumothorax: a systematic review and meta-analysis. J Surg Res. 2017;210:32–46.
   PubMed Web of Science ®Google Scholar
• Rokicki W, Rokicki M, Wojtacha J, et al. Is it possible to standardize the treatment of primary spontaneous pneumothorax? Part 2: surgical methods of treatment. Kardiochirurgia i torakochirurgia polska = Pol J Cardio-Thoracic Surg. 2016;13(4):328–333.
   PubMed Web of Science ®Google Scholar
• Elsayed HH, Hassaballa A, Ahmed T. Is video-assisted thoracoscopic surgery talc pleurodesis superior to talc pleurodesis via tube thoracostomy in patients with secondary spontaneous pneumothorax? Interact Cardiovasc Thorac Surg. 2016;23(3):459–461.
   PubMed Web of Science ®Google Scholar
• Noda M, Watanabe T, Matsuda Y, et al. Awake thoracic surgery versus chemical pleurodesis for intractable secondary spontaneous pneumothorax. Surg Today. 2016;46(11):1268–1274.
   PubMed Web of Science ®Google Scholar
• Chung WJ, Jo WM, Lee SH, et al. Effects of additional pleurodesis with dextrose and talc-dextrose solution after video assisted thoracoscopic procedures for primary spontaneous pneumothorax. J Korean Med Sci. 2008;23(2):284–287.
   PubMed Web of Science ®Google Scholar
• Cardillo G, Carleo F, Giunti R, et al. Videothoracoscopic talc poudrage in primary spontaneous pneumothorax: a single-institution experience in 861 cases. J Thorac Cardiovasc Surg. 2006;131(2):322–328.
   PubMed Web of Science ®Google Scholar
• Sepehripour AH, Nasir A, Shah R. Does mechanical pleurodesis result in better outcomes than chemical pleurodesis for recurrent primary spontaneous pneumothorax? Interact Cardiovasc Thorac Surg. 2012;14(3):307–311.
   PubMed Web of Science ®Google Scholar
• Chen JS, Hsu HH, Huang PM, et al. Thoracoscopic pleurodesis for primary spontaneous pneumothorax with high recurrence risk: a prospective randomized trial. Ann Surg. 2012;255(3):440–445.
   PubMed Web of Science ®Google Scholar
• Vargas FS, Milanez JR, Filomeno LT, et al. Intrapleural talc for the prevention of recurrence in benign or undiagnosed pleural effusions. Chest. 1994;106(6):1771–1775.
   PubMed Web of Science ®Google Scholar
• Glazer M, Berkman N, Lafair JS, et al. Successful talc slurry pleurodesis in patients with nonmalignant pleural effusion. Chest. 2000;117(5):1404–1409.
   PubMed Web of Science ®Google Scholar
• Steger V, Mika U, Toomes H, et al. Who gains most? A 10-year experience with 611 thoracoscopic talc pleurodeses. Ann Thorac Surg. 2007;83(6):1940–1945.
   PubMed Web of Science ®Google Scholar
• Schild HH, Strassburg CP, Welz A, et al. Treatment options in patients with chylothorax. Deutsches Ärzteblatt Int. 2013;110(48):819–826.
   PubMed Web of Science ®Google Scholar
• Mercer R, Macready J, Jeffries H, et al. S129 Does inflammation predict successful pleurodesis? A post hoc analysis from the time 1 trial. Thorax. 2017;72:A7–A8.
   Google Scholar
• Psathakis K, Calderón-Osuna E, Romero-Romero B, et al. The neutrophilic and fibrinolytic response to talc can predict the outcome of pleurodesis. Eur Respir J. 2006;27(4):817.
   PubMed Web of Science ®Google Scholar
• Montes-Worboys A, Rodriguez-Portal JA, Arellano-Orden E, et al. Interleukin-8 activates coagulation and correlates with survival after talc pleurodesis. Eur Respir J. 2010;35(1):160.
   PubMed Web of Science ®Google Scholar
• Aydogmus U, Ozdemir S, Cansever L, et al. Bedside talc pleurodesis for malignant pleural effusion: factors affecting success. Ann Surg Oncol. 2009;16(3):745–750.
   PubMed Web of Science ®Google Scholar
• Ak G, Metintas M, Yildirim H, et al. Pleurodesis in follow-up and treatment of malignant pleural mesothelioma patients. Tuberk Toraks. 2009;57(1):22–31.
   PubMedGoogle Scholar
• Goodman A, Davies CW. Efficacy of short-term versus long-term chest tube drainage following talc slurry pleurodesis in patients with malignant pleural effusions: a randomised trial. Lung Cancer. 2006;54(1):51–55.
   PubMed Web of Science ®Google Scholar
• Rahman NM, Singanayagam A, Davies HE, et al. Diagnostic accuracy, safety and utilisation of respiratory physician-delivered thoracic ultrasound. Thorax. 2010;65(5):449–453.
   PubMed Web of Science ®Google Scholar
• Lansley SM, Varano Della Vergiliana JF, Cleaver AL, et al. A commercially available preparation of Staphylococcus aureus bio-products potently inhibits tumour growth in a murine model of mesothelioma. Respirology (Carlton, Vic). 2014;19(7):1025–1033.
   PubMed Web of Science ®Google Scholar
• Nasreen N, Mohammed KA, Dowling PA, et al. Talc induces apoptosis in human malignant mesothelioma cells in vitro. Am J Respir Crit Care Med. 2000;161(2 Pt 1):595–600.
   PubMed Web of Science ®Google Scholar
• Ryu JS, Ryu HJ, Lee SN, et al. Prognostic impact of minimal pleural effusion in non-small-cell lung cancer. J Clin Oncol. 2014;32(9):960–967.
   PubMed Web of Science ®Google Scholar
• Cheah HM, Lansley SM, Varano Della Vergiliana JF, et al. Malignant pleural fluid from mesothelioma has potent biological activities. Respirology (Carlton, Vic). 2017;22(1):192–199.
   PubMed Web of Science ®Google Scholar
• Bethune N. Pleural poudrage: new technique for deliberate production of pleural adhesions as preliminary to lobectomy. J Thorac Surg. 1935;4:251.
   Google Scholar
• Genofre EH, Marchi E, Vargas FS. Inflammation and clinical repercussions of pleurodesis induced by intrapleural talc administration. Clinics (Sao Paulo, Brazil). 2007;62(5):627–634.
   PubMed Web of Science ®Google Scholar